Find slides from real investment banking decks

Comparison slide 26 from Aeglea Biotherapeutics — Corporate Overview

Chart slide 27 from Aeglea Biotherapeutics — Corporate Overview

Comparison slide 28 from Aeglea Biotherapeutics — Corporate Overview

Chart slide 29 from Aeglea Biotherapeutics — Corporate Overview

Table slide 30 from Aeglea Biotherapeutics — Corporate Overview

Chart slide 31 from Aeglea Biotherapeutics — Corporate Overview

Comparison slide 32 from Aeglea Biotherapeutics — Corporate Overview

Comparison slide 33 from Aeglea Biotherapeutics — Corporate Overview

Comparison slide 34 from Aeglea Biotherapeutics — Corporate Overview

Chart slide 35 from Aeglea Biotherapeutics — Corporate Overview

Framework slide 36 from Aeglea Biotherapeutics — Corporate Overview

Chart slide 37 from Aeglea Biotherapeutics — Corporate Overview

Table slide 38 from Aeglea Biotherapeutics — Corporate Overview

Framework slide 39 from Aeglea Biotherapeutics — Corporate Overview

Chart slide 40 from Aeglea Biotherapeutics — Corporate Overview

Comparison slide 41 from Aeglea Biotherapeutics — Corporate Overview

Process slide 42 from Aeglea Biotherapeutics — Corporate Overview

Framework slide 43 from Aeglea Biotherapeutics — Corporate Overview

Framework slide 44 from Aeglea Biotherapeutics — Corporate Overview

Comparison slide 45 from Aeglea Biotherapeutics — Corporate Overview

Cover slide 46 from Aeglea Biotherapeutics — Corporate Overview

Team slide 47 from Aeglea Biotherapeutics — Corporate Overview

Timeline slide 48 from Aeglea Biotherapeutics — Corporate Overview

Comparison slide 49 from Aeglea Biotherapeutics — Corporate Overview

Table slide 50 from Aeglea Biotherapeutics — Corporate Overview

Closing slide 51 from Aeglea Biotherapeutics — Corporate Overview

Team slide 52 from Aeglea Biotherapeutics — Corporate Overview

Framework slide 53 from Aeglea Biotherapeutics — Corporate Overview

Framework slide 54 from Aeglea Biotherapeutics — Corporate Overview

Comparison slide 55 from Aeglea Biotherapeutics — Corporate Overview

Chart slide 56 from Aeglea Biotherapeutics — Corporate Overview